Creative Planning Aurinia Pharmaceuticals Inc. Transaction History

Creative Planning

$116 Billion
Q2 2025

A detailed history of Creative Planning transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Creative Planning holds 20,699 shares of AUPH stock, worth $250,871. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,699

Previous 17,105 21.01%

Holding current value

$250,871

Previous $137,000 27.74%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$7.2 - $8.64 $25,876 - $31,052	3,594 Added 21.01%	20,699 $175,000
Q1 2025 May 15, 2025	BUY	$7.55 - $8.77 $7,346 - $8,533	973 Added 6.03%	17,105 $137,000
Q4 2024 Feb 14, 2025	BUY	$6.75 - $10.44 $9,794 - $15,148	1,451 Added 9.88%	16,132 $144,000
Q3 2024 Oct 11, 2024	SELL	$5.32 - $7.33 $3,532 - $4,867	-664 Reduced 4.33%	14,681 $107,000
Q2 2024 Aug 15, 2024	BUY	$4.81 - $5.78 $73,809 - $88,694	15,345 New	15,345 $87,000
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $81,167 - $108,034	11,384 New	11,384 $102,000
Q2 2021 Aug 04, 2021	SELL	$10.0 - $14.52 $641,300 - $931,167	-64,130 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$12.3 - $18.73 $36,838 - $56,096	2,995 Added 4.9%	64,130 $833,000
Q4 2020 Jan 29, 2021	SELL	$12.94 - $16.05 $146,027 - $181,124	-11,285 Reduced 15.58%	61,135 $845,000
Q3 2020 Nov 05, 2020	BUY	$13.19 - $16.66 $55,661 - $70,305	4,220 Added 6.19%	72,420 $1.07 Million
Q2 2020 Jul 23, 2020	SELL	$14.12 - $18.33 $4,236 - $5,498	-300 Reduced 0.44%	68,200 $1.11 Million
Q1 2020 May 05, 2020	SELL	$11.34 - $21.46 $2.24 Million - $4.23 Million	-197,200 Reduced 74.22%	68,500 $994,000
Q4 2019 Jan 30, 2020	BUY	$3.88 - $21.42 $221,160 - $1.22 Million	57,000 Added 27.31%	265,700 $5.38 Million
Q1 2019 Apr 24, 2019	BUY	$6.06 - $7.64 $248,720 - $313,568	41,043 Added 24.48%	208,700 $1.36 Million
Q4 2018 Feb 01, 2019	BUY	$5.08 - $6.83 $78,521 - $105,571	15,457 Added 10.16%	167,657 $1.14 Million
Q3 2018 Oct 25, 2018	SELL	$5.27 - $6.64 $100,129 - $126,160	-19,000 Reduced 11.1%	152,200 $1.01 Million
Q2 2018 Jul 20, 2018	BUY	$5.06 - $6.36 $65,780 - $82,680	13,000 Added 8.22%	171,200 $964,000
Q1 2018 Apr 18, 2018	BUY	$4.85 - $5.99 $38,800 - $47,920	8,000 Added 5.33%	158,200 $821,000
Q3 2017 Oct 17, 2017	BUY	$5.71 - $6.9 $857,642 - $1.04 Million	150,200	150,200 $942,000

Others Institutions Holding AUPH

# of Institutions

249

Shares Held

62.6M

Call Options Held

1.03M

Put Options Held

666K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.72B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Aurinia Pharmaceuticals Inc. Transaction History